603233 大参林
交易中 12-09 09:30:07
资讯
新帖
简况
大参林陷医保套刷风波，激进转型背后的三大风险
新浪证券 · 11-28
大参林陷医保套刷风波，激进转型背后的三大风险
每周股票复盘：大参林（603233）取消监事会并修订多项制度
证券之星 · 11-23
每周股票复盘：大参林（603233）取消监事会并修订多项制度
大参林（603233）披露取消监事会并修订公司章程等议案，11月21日股价下跌0.68%
证券之星 · 11-21
大参林（603233）披露取消监事会并修订公司章程等议案，11月21日股价下跌0.68%
每周股票复盘：大参林（603233）拟取消监事会改由董事会审计委员会履职
证券之星 · 11-09
每周股票复盘：大参林（603233）拟取消监事会改由董事会审计委员会履职
大参林（603233）披露拟取消监事会并调整公司治理结构，11月07日股价上涨1.5%
证券之星 · 11-07
大参林（603233）披露拟取消监事会并调整公司治理结构，11月07日股价上涨1.5%
东吴证券：给予大参林买入评级
证券之星 · 11-02
东吴证券：给予大参林买入评级
盘中涨近2%！大参林Q3净利同比增41.04%扣非归母净利润同比增长47.01%
滚动播报 · 10-31
盘中涨近2%！大参林Q3净利同比增41.04%扣非归母净利润同比增长47.01%
大参林（603233）披露拟取消监事会并修订公司章程议案，10月29日股价下跌0.38%
证券之星 · 10-29
大参林（603233）披露拟取消监事会并修订公司章程议案，10月29日股价下跌0.38%
大参林：不存在逾期对外担保情况
证券日报 · 10-29
大参林：不存在逾期对外担保情况
图解大参林三季报：第三季度单季净利润同比增长41.04%
证券之星 · 10-29
图解大参林三季报：第三季度单季净利润同比增长41.04%
每周股票复盘：大参林（603233）大参转债将因分红暂停转股
证券之星 · 10-26
每周股票复盘：大参林（603233）大参转债将因分红暂停转股
大参林（603233）披露关于实施2025年半年度权益分派时“大参转债”停止转股的提示性公告，10月23日股价上涨1.48%
证券之星 · 10-23
大参林（603233）披露关于实施2025年半年度权益分派时“大参转债”停止转股的提示性公告，10月23日股价上涨1.48%
每周股票复盘：大参林（603233）大参转债2025年付息1.80元/张
证券之星 · 10-19
每周股票复盘：大参林（603233）大参转债2025年付息1.80元/张
大参林（603233）披露可转换公司债券2025年付息公告，10月14日股价上涨1.14%
证券之星 · 10-14
大参林（603233）披露可转换公司债券2025年付息公告，10月14日股价上涨1.14%
每周股票复盘：大参林（603233）大参转债累计转股6,242股
证券之星 · 10-12
每周股票复盘：大参林（603233）大参转债累计转股6,242股
大参林（603233）披露可转债转股结果暨股份变动公告，10月09日股价上涨0.73%
证券之星 · 10-09
大参林（603233）披露可转债转股结果暨股份变动公告，10月09日股价上涨0.73%
每周股票复盘：大参林（603233）将召开2025年半年度业绩说明会
证券之星 · 09-21
每周股票复盘：大参林（603233）将召开2025年半年度业绩说明会
大参林（603233）披露召开2025年半年度业绩说明会公告，9月17日股价上涨2.56%
证券之星 · 09-17
大参林（603233）披露召开2025年半年度业绩说明会公告，9月17日股价上涨2.56%
每周股票复盘：大参林（603233）现8笔大宗交易 机构净买入3.74亿元
证券之星 · 09-14
每周股票复盘：大参林（603233）现8笔大宗交易 机构净买入3.74亿元
9月10日大参林发布公告，股东减持2270万股
证券之星 · 09-10
9月10日大参林发布公告，股东减持2270万股
加载更多
公司概况
公司名称：
大参林医药集团股份有限公司
所属行业：
零售业
上市日期：
2017-07-31
主营业务：
大参林医药集团股份有限公司的主营业务是中西成药、参茸滋补药材及中药饮片、保健品、医疗器械及其他商品的连锁零售业务。公司的主要产品是中西成药、中参药材、非药品。“大参林”已成为“中国驰名商标”和“广东省著名商标”。公司已成为中国门店规模及销售规模最大的连锁药房，并获得“2024-2025年度中国药店价值榜第一名”等荣誉。
发行价格：
24.72
{"stockData":{"symbol":"603233","market":"SH","secType":"STK","nameCN":"大参林","latestPrice":17.44,"timestamp":1765243807000,"preClose":17.47,"halted":0,"volume":36300,"delay":0,"changeRate":-0.0017,"floatShares":1139000000,"shares":1139000000,"eps":0.999,"marketStatus":"交易中","change":-0.03,"latestTime":"12-09 09:30:07","open":17.48,"high":17.48,"low":17.44,"amount":634400,"amplitude":0.0023,"askPrice":17.44,"askSize":7,"bidPrice":17.43,"bidSize":5,"shortable":0,"etf":0,"ttmEps":0.999,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1765251000000},"marketStatusCode":2,"adr":0,"adjPreClose":17.47,"symbolType":"stock","openAndCloseTimeList":[[1765243800000,1765251000000],[1765256400000,1765263600000]],"highLimit":19.22,"lowLimit":15.72,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1138847895,"isCdr":false,"pbRate":2.83,"roa":"--","peRate":17.457457,"roe":"14.85%","epsLYR":0.81,"committee":-0.037736,"marketValue":19862000000,"turnoverRate":0,"status":1,"floatMarketCap":19862000000},"requestUrl":"/m/hq/s/603233","defaultTab":"news","newsList":[{"id":"2586204859","title":"大参林陷医保套刷风波，激进转型背后的三大风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2586204859","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586204859?lang=zh_cn&edition=full","pubTime":"2025-11-28 15:52","pubTimestamp":1764316320,"startTime":"0","endTime":"0","summary":"连锁药店龙头大参林（维权）正面临一场由内而外的合规与增长考验。11月，央视财经曝光部分药店通过将日用品串换为医疗器械“套刷”医保卡，大参林门店卷入其中。然而，急转型背后，风险已然浮现。 央视调查发现，大参林某门店将防晒冰袖、口罩标注为“医用隔离垫”，以此规避医保使用限制。 大参林的困境是连锁药店行业的缩影：在医保红利消退与线上渠道冲击下，企业被迫转型，却陷入“合规、供应链、资本”的三重挑战。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2025-11-28/doc-infyxwfh7409380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0114","BK0209","603233","BK0185"],"gpt_icon":0},{"id":"2585993105","title":"每周股票复盘：大参林（603233）取消监事会并修订多项制度","url":"https://stock-news.laohu8.com/highlight/detail?id=2585993105","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585993105?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:43","pubTimestamp":1763840591,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，大参林报收于17.57元，较上周的18.61元下跌5.59%。本周，大参林11月17日盘中最高价报18.59元。大参林当前最新总市值200.1亿元，在医药商业板块市值排名5/32，在两市A股市值排名913/5167。本周关注点公司公告汇总：大参林召开2025年第三次临时股东会，审议通过取消监事会并修订公司章程及相关治理制度。会议由董事会召集，董事柯国强主持，采用现场与网络投票方式召开，表决程序合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","603233","BK0114","BK0209"],"gpt_icon":0},{"id":"2585141858","title":"大参林（603233）披露取消监事会并修订公司章程等议案，11月21日股价下跌0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585141858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585141858?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:41","pubTimestamp":1763736065,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，大参林报收于17.57元，较前一交易日下跌0.68%，最新总市值为200.1亿元。该股当日开盘17.69元，最高17.85元，最低17.45元，成交额达1.1亿元，换手率为0.55%。近日，大参林医药集团股份有限公司发布2025年第三次临时股东会决议公告，会议审议通过了关于取消监事会并修订《公司章程》及附件的议案、修订《独立董事制度》的议案，以及修订《对外投资管理制度》《对外担保管理制度》《关联交易管理制度》的议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100040647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0209","BK0185","603233"],"gpt_icon":0},{"id":"2582610128","title":"每周股票复盘：大参林（603233）拟取消监事会改由董事会审计委员会履职","url":"https://stock-news.laohu8.com/highlight/detail?id=2582610128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582610128?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:37","pubTimestamp":1762634230,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，大参林报收于18.29元，较上周的18.28元上涨0.05%。本周，大参林11月4日盘中最高价报18.62元。大参林当前最新总市值208.3亿元，在医药商业板块市值排名5/32，在两市A股市值排名935/5166。本周关注点公司公告汇总：大参林拟取消监事会，由董事会审计委员会履行其职权公司公告汇总大参林医药集团股份有限公司拟取消监事会，由董事会审计委员会履行监事会职权，并修订《公司章程》及附件，调整公司治理结构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","603233","BK0185","BK0114"],"gpt_icon":0},{"id":"2581288154","title":"大参林（603233）披露拟取消监事会并调整公司治理结构，11月07日股价上涨1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581288154","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581288154?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:37","pubTimestamp":1762526244,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，大参林报收于18.29元，较前一交易日上涨1.5%，最新总市值为208.3亿元。该股当日开盘18.03元，最高18.5元，最低17.98元，成交额达1.08亿元，换手率为0.52%。近日，大参林医药集团股份有限公司发布《2025年第三次临时股东会会议材料》公告，宣布拟取消监事会，由董事会审计委员会履行监事会职权，并修订《公司章程》及附件，调整公司治理结构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700039397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0209","BK0185","603233"],"gpt_icon":0},{"id":"2580404072","title":"东吴证券：给予大参林买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2580404072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580404072?lang=zh_cn&edition=full","pubTime":"2025-11-02 14:25","pubTimestamp":1762064718,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广,冉胜男,苏丰近期对大参林进行研究并发布了研究报告《2025年三季报点评：25Q3盈利超预期，降本增效成果显著》，给予大参林买入评级。最新盈利预测明细如下：该股最近90天内共有10家机构给出评级，买入评级7家，增持评级3家；过去90天内机构目标均价为20.23。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200003657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233","601555"],"gpt_icon":0},{"id":"2579489488","title":"盘中涨近2%！大参林Q3净利同比增41.04%扣非归母净利润同比增长47.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579489488","media":"滚动播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579489488?lang=zh_cn&edition=full","pubTime":"2025-10-31 09:54","pubTimestamp":1761875640,"startTime":"0","endTime":"0","summary":" 单季度看，2025年第三季度公司实现收入65.5亿元，同比增长2.51%；归母净利润2.8亿元，同比增长41.04%；扣非归母净利润2.8亿元，同比增长47.01%。 公司日前发布2025年第三季度报告显示，2025年前三季度，公司实现收入200.7亿元，同比增长1.71%；实现归母净利润10.8亿元，同比增长25.97%；实现扣非归母净利润10.7亿元，同比增长25.93%。 具体来看，公司中西成药收入为154.5亿元，同比增长5.01%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-10-30/doc-infvscvr9547583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603233"],"gpt_icon":0},{"id":"2579907250","title":"大参林（603233）披露拟取消监事会并修订公司章程议案，10月29日股价下跌0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579907250","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579907250?lang=zh_cn&edition=full","pubTime":"2025-10-29 22:32","pubTimestamp":1761748321,"startTime":"0","endTime":"0","summary":"截至2025年10月29日收盘，大参林报收于18.17元，较前一交易日下跌0.38%，最新总市值为206.93亿元。该股当日开盘18.2元，最高18.24元，最低17.89元，成交额达7696.61万元，换手率为0.37%。本次股东会审议事项包括：关于取消监事会并修订《公司章程》及附件的议案、关于修订《独立董事制度》的议案、关于修订《对外投资管理制度》的议案、关于修订《对外担保管理制度》的议案以及关于修订《关联交易管理制度》的议案。股权登记日为2025年11月14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900045522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0114","BK0185","603233"],"gpt_icon":0},{"id":"2579901516","title":"大参林：不存在逾期对外担保情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2579901516","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579901516?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:45","pubTimestamp":1761741900,"startTime":"0","endTime":"0","summary":"证券日报网讯 10月29日晚间，大参林（维权）发布公告称，截至本公告披露日，公司及其子公司对外担保余额为人民币417，750万元，占公司最近一期经审计的归属于上市公司股东净资产的比例为51.33%。上述对外担保总额全部为公司对控股子公司提供的担保，公司不存在对控股股东和实际控制人及其关联人提供担保情况，也不存在逾期对外担保情况。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-29/doc-infvqmni0125434.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-29/doc-infvqmni0125434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0114","BK0209","603233","BK0185"],"gpt_icon":0},{"id":"2579493903","title":"图解大参林三季报：第三季度单季净利润同比增长41.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579493903","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579493903?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:14","pubTimestamp":1761740067,"startTime":"0","endTime":"0","summary":"证券之星消息，大参林2025年三季报显示，前三季度公司主营收入200.68亿元，同比上升1.71%；归母净利润10.81亿元，同比上升25.97%；扣非净利润10.73亿元，同比上升25.93%；其中2025年第三季度，公司单季度主营收入65.46亿元，同比上升2.51%；单季度归母净利润2.83亿元，同比上升41.04%；单季度扣非净利润2.84亿元，同比上升47.01%；负债率67.45%，投资收益411.92万元，财务费用1.21亿元，毛利率34.82%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900041351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233"],"gpt_icon":0},{"id":"2578153504","title":"每周股票复盘：大参林（603233）大参转债将因分红暂停转股","url":"https://stock-news.laohu8.com/highlight/detail?id=2578153504","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578153504?lang=zh_cn&edition=full","pubTime":"2025-10-26 02:31","pubTimestamp":1761417069,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，大参林报收于18.68元，较上周的17.5元上涨6.74%。本周，大参林10月23日盘中最高价报19.35元，股价触及近一年最高点。本周关注点公司公告汇总：大参转债将于2025年10月29日起暂停转股，直至权益分派股权登记日后首个交易日恢复。公司公告汇总大参林医药集团股份有限公司因实施2025年半年度权益分派，“大参转债”将停止转股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","603233","BK0185","BK0114"],"gpt_icon":0},{"id":"2577737453","title":"大参林（603233）披露关于实施2025年半年度权益分派时“大参转债”停止转股的提示性公告，10月23日股价上涨1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577737453","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577737453?lang=zh_cn&edition=full","pubTime":"2025-10-23 17:18","pubTimestamp":1761211137,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，大参林报收于19.2元，较前一交易日上涨1.48%，最新总市值为218.66亿元。该股当日开盘18.9元，最高19.35元，最低18.77元，成交额达2.05亿元，换手率为0.94%。同日，大参林医药集团股份有限公司发布公告，就公司实施2025年半年度权益分派期间“大参转债”停止转股事项作出提示。权益分派实施后，公司将对“大参转债”当期转股价格进行调整，并于2025年10月30日发布相关实施公告及转股价格调整公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300026750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233","BK0209","BK0185","BK0114"],"gpt_icon":0},{"id":"2576410840","title":"每周股票复盘：大参林（603233）大参转债2025年付息1.80元/张","url":"https://stock-news.laohu8.com/highlight/detail?id=2576410840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576410840?lang=zh_cn&edition=full","pubTime":"2025-10-19 04:49","pubTimestamp":1760820546,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，大参林报收于17.5元，较上周的16.72元上涨4.67%。本周，大参林10月16日盘中最高价报17.7元。本周关注点公司公告汇总：大参林将于2025年10月22日支付“大参转债”第五年利息，每张兑息1.80元（含税）。公司公告汇总：本次付息债权登记日为2025年10月21日，除息日与付息日均为10月22日。付息对象为截至债权登记日在中国证券登记结算有限责任公司上海分公司登记在册的全体“大参转债”持有人。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900001020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","603233","BK0114","BK0209"],"gpt_icon":0},{"id":"2575821474","title":"大参林（603233）披露可转换公司债券2025年付息公告，10月14日股价上涨1.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575821474","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575821474?lang=zh_cn&edition=full","pubTime":"2025-10-14 22:55","pubTimestamp":1760453718,"startTime":"0","endTime":"0","summary":"近日，大参林医药集团股份有限公司发布关于可转换公司债券2025年付息的公告。公告称，公司将于2025年10月22日支付“大参转债”第五年利息，计息期间为2024年10月22日至2025年10月21日，票面利率为1.80%（含税），每张兑息1.80元。债权登记日为2025年10月21日，除息日及付息日均为2025年10月22日。付息对象为截至债权登记日在中国证券登记结算有限责任公司上海分公司登记在册的全体“大参转债”持有人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400065773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0114","603233","BK0185"],"gpt_icon":0},{"id":"2574463513","title":"每周股票复盘：大参林（603233）大参转债累计转股6,242股","url":"https://stock-news.laohu8.com/highlight/detail?id=2574463513","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574463513?lang=zh_cn&edition=full","pubTime":"2025-10-12 03:50","pubTimestamp":1760212222,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，大参林报收于16.72元，较上周的16.49元上涨1.39%。本周，大参林10月10日盘中最高价报16.8元。10月9日盘中最低价报16.31元。大参林当前最新总市值190.42亿元，在医药商业板块市值排名5/32，在两市A股市值排名1001/5158。2025年第三季度无新增转股。尚未转股的可转债金额为1,404,638,000元，占发行总量的99.9742%。转股价格经多次调整，最新为17.69元/股。股本变动方面，总股本保持1,138,847,895股不变。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200001018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0114","603233","BK0209"],"gpt_icon":0},{"id":"2574161899","title":"大参林（603233）披露可转债转股结果暨股份变动公告，10月09日股价上涨0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574161899","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574161899?lang=zh_cn&edition=full","pubTime":"2025-10-09 23:04","pubTimestamp":1760022259,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘，大参林报收于16.61元，较前一交易日上涨0.73%，最新总市值为189.16亿元。近日，大参林医药集团股份有限公司发布可转债转股结果暨股份变动公告。公告显示，截至2025年9月30日，累计有362,000元“大参转债”转换为公司股份，占可转债发行总量的0.0258%；累计转股数量6,242股，占转股前公司已发行股份总额的0.0009%。2025年第三季度无新增转股。股本变动方面，总股本保持1,138,847,895股不变。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900034988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0209","BK0185","603233"],"gpt_icon":0},{"id":"2569249869","title":"每周股票复盘：大参林（603233）将召开2025年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2569249869","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569249869?lang=zh_cn&edition=full","pubTime":"2025-09-21 05:02","pubTimestamp":1758402143,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，大参林报收于17.34元，较上周的17.38元下跌0.23%。本周关注点公司公告汇总：大参林将于2025年9月26日召开2025年半年度业绩说明会。本次股东大会于2025年9月15日以现场和网络投票方式召开，会议由董事柯国强主持。大参林医药集团股份有限公司将于2025年9月26日（星期五）下午16:00-17:00通过上海证券交易所上证路演中心以网络互动方式召开2025年半年度业绩说明会，就公司2025年半年度经营情况及财务状况与投资者进行交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100001299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233","BK0209","BK0114","BK0185"],"gpt_icon":0},{"id":"2568497763","title":"大参林（603233）披露召开2025年半年度业绩说明会公告，9月17日股价上涨2.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568497763","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568497763?lang=zh_cn&edition=full","pubTime":"2025-09-17 23:02","pubTimestamp":1758121339,"startTime":"0","endTime":"0","summary":"截至2025年9月17日收盘，大参林报收于17.66元，较前一交易日上涨2.56%，最新总市值为201.12亿元。该股当日开盘17.24元，最高17.69元，最低17.24元，成交额达1.26亿元，换手率为0.63%。近日，大参林医药集团股份有限公司发布公告称，公司将于2025年9月26日（星期五）下午16:00-17:00通过上海证券交易所上证路演中心以网络互动方式召开2025年半年度业绩说明会，就公司2025年半年度经营情况及财务状况与投资者进行交流。会后可通过上证路演中心查看会议主要内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700040801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0185","603233","BK0114"],"gpt_icon":0},{"id":"2567133220","title":"每周股票复盘：大参林（603233）现8笔大宗交易 机构净买入3.74亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567133220","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567133220?lang=zh_cn&edition=full","pubTime":"2025-09-14 02:49","pubTimestamp":1757789356,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，大参林报收于17.38元，较上周的17.17元上涨1.22%。本周，大参林9月9日盘中最高价报17.89元。股本股东变化：股东柯金龙减持2270.0万股，占总股本1.9932%。交易信息汇总9月9日大参林发生8笔大宗交易，机构净买入3.74亿元。公司公告汇总大参林医药集团股份有限公司于2025年9月11日公告，持股5%以上股东柯金龙减持计划实施完毕。本次减持后，柯金龙持股由229,631,849股降至206,931,849股，持股比例由20.16%降至18.17%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400000565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","603233","BK0114","BK0209"],"gpt_icon":0},{"id":"2566160571","title":"9月10日大参林发布公告，股东减持2270万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2566160571","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566160571?lang=zh_cn&edition=full","pubTime":"2025-09-10 20:01","pubTimestamp":1757505681,"startTime":"0","endTime":"0","summary":"证券之星消息，9月10日大参林发布公告《大参林:大参林医药集团股份有限公司关于持股5%以上股东权益变动触及1%刻度暨减持计划实施完毕的公告》，其股东柯金龙于2025年9月9日合计减持2270.0万股，占公司目前总股本的1.9932%，变动期间该股股价上涨0.11%，截止9月9日收盘报17.72元。股东增减持详情见下表：根据大参林2025年中报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091000033967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0114","BK0209","603233"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765243810809,"stockEarnings":[{"period":"1week","weight":-0.0443},{"period":"1month","weight":-0.0448},{"period":"3month","weight":0.0043},{"period":"6month","weight":0.094},{"period":"1year","weight":0.1597},{"period":"ytd","weight":0.2051}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0184},{"period":"3month","weight":0.0307},{"period":"6month","weight":0.1534},{"period":"1year","weight":0.1528},{"period":"ytd","weight":0.1708}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"大参林医药集团股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"28590人(较上一季度减少9.38%)","perCapita":"39833股","listingDate":"2017-07-31","address":"广东省广州市荔湾区龙溪大道410号、410-1号","registeredCapital":"113884万元","survey":" 大参林医药集团股份有限公司的主营业务是中西成药、参茸滋补药材及中药饮片、保健品、医疗器械及其他商品的连锁零售业务。公司的主要产品是中西成药、中参药材、非药品。“大参林”已成为“中国驰名商标”和“广东省著名商标”。公司已成为中国门店规模及销售规模最大的连锁药房，并获得“2024-2025年度中国药店价值榜第一名”等荣誉。","listedPrice":24.72},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"大参林(603233)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供大参林(603233)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"大参林,603233,大参林股票,大参林股票老虎,大参林股票老虎国际,大参林行情,大参林股票行情,大参林股价,大参林股市,大参林股票价格,大参林股票交易,大参林股票购买,大参林股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"大参林(603233)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供大参林(603233)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}